找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Lyophilized Biologics and Vaccines; Modality-Based Appro Dushyant Varshney,Manmohan Singh Book 2015 Springer Science+Business Media New Yor

[复制链接]
楼主: 轻舟
发表于 2025-3-23 12:36:39 | 显示全部楼层
发表于 2025-3-23 16:24:55 | 显示全部楼层
发表于 2025-3-23 18:33:14 | 显示全部楼层
Advance Understanding of Buffer Behavior during Lyophilizationto maintain biologic activity. The control of pH throughout the lyophilization process is critical to maintaining biologic activity and an acceptable shelf life. In this chapter, the critical aspects of selecting a buffer that achieves optimal stability throughout the freeze-drying process and on su
发表于 2025-3-24 00:39:01 | 显示全部楼层
Advances in Instrumental Analysis Applied to the Development of Lyophilization Cyclesdevelopment is framed in the context of the recent International Conference on Harmonization Q8 R2 guidance and the quality-by-design (QbD) approach which focuses on the generation of a design space using well-known heat and mass transfer principles. The chapter briefly reviews analytical approaches
发表于 2025-3-24 05:42:16 | 显示全部楼层
发表于 2025-3-24 06:55:24 | 显示全部楼层
Lyophilized Biologics advantages and disadvantages of lyophilized formulations are important to consider when making product decisions. A clear understanding of why, when, and how to develop lyophilized formulations in a phase-appropriate fashion are essential, considering lyophilized formulations may be perceived as le
发表于 2025-3-24 12:42:39 | 显示全部楼层
Lyophilization of Therapeutic Proteins in Vials: Process Scale-Up and Advances in Quality by Designned through building a scalable freezing step in terms of ice nucleation along with the generation of a primary drying design space. Applying QbD to the design of the cycle allows for the consideration of scalability up front, removing the traditional “trial-and-error” approach, while understanding
发表于 2025-3-24 18:02:14 | 显示全部楼层
发表于 2025-3-24 20:36:15 | 显示全部楼层
Process Scale-Up and Optimization of Lyophilized Vaccine Productsof infectious diseases. Relative to therapeutic proteins (TPs) and small molecules, vaccine drug product development is more challenging and it is often stated that the “process is product” especially for live virus vaccines (LVVs). Given the global outreach of vaccines and the corresponding impact
发表于 2025-3-25 02:16:01 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-30 11:01
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表